Today's Daily Dose brings you news about Aurinia Pharma's near-term regulatory catalyst, Alector gearing up to report frontotemporal dementia trial results next week, the progress in Arcturus' LUNAR-COV19 vaccine, Biohaven completing enrolment in phase III trial of Verdiperstat in multiple system atrophy, and InflaRx' update on its investigational drug IFX-1 in severe COVID-19- induced pneumonia.
from RTT - Biotech https://ift.tt/2WKpgyn
via IFTTT
No comments:
Post a Comment